Similar Articles
531 Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directions
532 Surveillance for hepatocellular carcinoma at the community level: Easier said than done
533 Extremely high titer of hepatitis B surface antigen antibodies in a primary hepatocellular carcinoma patient: A case report
534 Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
535 Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice
536 Trends of rapamycin in survival benefits of liver transplantation for hepatocellular carcinoma
537 Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment
538 Improving nutrition for the prevention of gestational diabetes: Current status and perspectives
539 Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy
540 Characterization of metabolic landscape in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA